Search

Displaying results 8771 - 8780 of 10000 in total
  1. Drug

    Rilematovir

    go.drugbank.com/drugs/DB15672
    Investigational

    Rilematovir is under investigation in clinical trial NCT04056611 (Effects of JNJ-53718678 in Adult and Adolescent Participants Who Had a Hematopoietic Stem Cell Transplantation and Who Are Infected With

  2. Drug

    Nivatrotamab

    go.drugbank.com/drugs/DB16654
    Investigational

    Osteosarcoma and Other Solid Tumor Cancers). … Nivatrotamab is under investigation in clinical trial NCT03860207 (Study of the Safety and Efficacy of Humanized 3F8 Bispecific Antibody (Hu3f8-bsab) in Patients With Relapsed/refractory Neuroblastoma,

  3. Drug

    Carbomer

    go.drugbank.com/drugs/DB15649
    Investigational

    Mixtures: RUNYI MIAOJIE Hand sanitizer, RUNYI MIAOJIE Hand sanitizer
  4. Drug

    Syrosingopine

    go.drugbank.com/drugs/DB19379
    ApprovedWithdrawn

    Categories: syrosingopine and diuretics
  5. Drug

    Aldoxorubicin

    go.drugbank.com/drugs/DB06013
    Investigational

    Aldoxorubicin, an antineoplastic agents, is an albumin-binding prodrug of doxorubicin.

  6. Drug

    Retosiban

    go.drugbank.com/drugs/DB11818
    Investigational

    Retosiban has been used in trials studying the treatment of Premature Labor and Obstetric Labour, Premature.

  7. Drug

    LY-2090314

    go.drugbank.com/drugs/DB11913
    Investigational

    Ly2090314 has been used in trials studying the treatment of Leukemia, Advanced Cancer, and Pancreatic Cancer.

  8. Drug

    Evodenoson

    go.drugbank.com/drugs/DB12295
    Investigational

    Evodenoson has been used in trials studying the treatment of Open-angle Glaucoma and Ocular Hypertension.

  9. Drug

    Perzinfotel

    go.drugbank.com/drugs/DB12365
    Investigational

    Perzinfotel has been used in trials studying the treatment of Diabetes Mellitus and Diabetic Neuropathy, Painful.

  10. Drug

    Fosravuconazole

    go.drugbank.com/drugs/DB15204
    Investigational

    Fosravuconazole is under investigation in clinical trial NCT03378661 (BENDITA BEnznidazole New Doses Improved Treatment and Associations).